Description
Rinvoq 15mg is a prescription, extended-release oral tablet containing upadacitinib,
a Janus kinase (JAK) inhibitor used to Rinvoq 15mg tablet online treat chronic inflammatory conditions like rheumatoid arthritis,
psoriatic arthritis, and atopic dermatitis. It reduces inflammation Rinvoq 15mg tablet price by blocking enzyme activity, taken once daily,
but carries risks of serious infections, blood clots, and Rinvoq 15mg tablet cancer.
Rheumatoid Arthritis (RA): Patients aged 18 or above who have moderately to severely active rheumatoid arthritis which does not respond adequately to previous DMARD or TNF blocking therapy. Psoriatic Arthritis (PsA): Patients aged 18 or above who have moderately to severely active PsA, inadequately responding to TNF blocker therapy.
Atopic Dermatitis (Eczema): Patients aged 18 or above or pediatric patients aged 12 years and older suffering from atopic dermatitis inadequately controlled by current therapies. Ankylosing Spondylitis & Non-radiographic Axial Spondyloarthritis: Adult patients with active spine involvement. Ulcerative Colitis & Crohn’s Disease: Patients with moderate to severe UC or Crohn’s disease.
Recommended dose: The prescribed dose for all above uses is generally \(15 \text{ mg}\) orally per day. How to take: Take as directed by your healthcare provider. Rinvoq tablet should be swallowed without splitting,
chewing, or crushing. Important warnings: Rinvoq may weaken your body’s immune responses against infection. Also, there are chances of severe cardiac events, blood clots, cancers along with use of this drug. Combination with other JAK inhibitors and immunosuppressants should not be considered.
Rinvoq (upadacitinib) acts as an immunosuppressant. This drug belongs to class “targeted synthetic DMARD” and acts as an inhibitor of parts of the immune.
